Specify the Steps of Information Manipulation or Lose under § 101 - In Mobile Acuity Ltd. v. Blippar Ltd. Appeal No. 22-2216, the Federal Circuit held that patent claims that merely recite result-orientated, functional...more
9/10/2024
/ Abbreviated New Drug Application (ANDA) ,
America Invents Act ,
Food and Drug Administration (FDA) ,
Intellectual Property Protection ,
International Trade Commission (ITC) ,
Motion to Dismiss ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Validity ,
Patent-Eligible Subject Matter ,
Patents ,
SCOTUS
Infringement Judgement is Only Final when there’s Nothing Left to Do but Execute - In Packet Intelligence LLC v. Netscout Systems, Inc., Appeal No. 22-2064, the Federal Circuit held that an infringement judgment is only...more
6/7/2024
/ Damages ,
Design Patent ,
Injury-in-Fact ,
Inter Partes Review (IPR) Proceeding ,
Licensing Rules ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Ownership ,
Patentability Search ,
Patents ,
Printed Matter Doctrine ,
Prior Art ,
Standing ,
Summary Judgment
Obviousness Analysis Does Not Consider Unclaimed Limitations - In Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals Usa, Inc., Appeal No. 22-1258, the Federal Circuit held that district court erred by adding unclaimed...more
The Outcome of the PTAB’s Analysis May Determine Whether the PTAB Engaged in Claim Construction -
In Google LLC v. Ecofactor, Inc., Appeal No. 22-1750, the Federal Circuit held that the outcome of the PTAB’s analysis of...more
3/5/2024
/ Administrative Procedure Act ,
Claim Construction ,
Google ,
Intellectual Property Protection ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Philip Morris ,
Prior Art
Substantial Evidence in Determining Obviousness -
In Schwendimann v. Neenah, Inc, Appeal No. 22-1335, the Federal Circuit held that the PTAB’s finding on obviousness is supported by substantial evidence that a skilled...more
IPR Petitioners Must Be Permitted to Respond to Claim Constructions First Proposed in Patent Owner Response -
In Axonics, Inc. v. Medtronic, Inc., Appeal No. 22-1532, the Federal Circuit held that where a patent owner in...more
9/20/2023
/ Claim Construction ,
Ex Parte ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Ownership ,
Patent Term Adjustment ,
Patent Term Extensions ,
Patent Trial and Appeal Board ,
Patents ,
USPTO
Objective Evidence in Determining Obviousness -
In Medtronic, Inc. v. Teleflex Innovations, Appeal No. 21-2357, the Federal Circuit held that a close prima facie case of obviousness can be overcome by strong evidence of...more
7/20/2023
/ Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Medical Devices ,
Medtronic ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prior Art
Arthrex Again? Federal Circuit Says, “No More!” -
In Cywee Group Ltd. v. Google LLC, Appeal No. 20-1565, the Federal Circuit held that, while the Appointments Clause requires that the USPTO Director have the power to...more
Claim Limitation Not Disclosed by Any Reference but Disclosed by “Proposed Combination” of References Is Obvious -
In Hoyt Augustus Fleming v. Cirrus Design Corporation, Appeal No. 21-1561, the Federal Circuit held that a...more
4/5/2022
/ Anticipation ,
Claim Construction ,
Claim Limitations ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Motion to Amend ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Sua Sponte ,
Substitute Claims
Ranges for Interdependent and Interactive Components Can Be Tricky to Derive -
In Modernatx, Inc. v. Arbutus Biopharma Corporation, Appeal No. 20-2329, the Federal Circuit held that a presumption of obviousness based on...more
1/11/2022
/ AstraZeneca ,
Generic Drugs ,
Instrinsic Evidence ,
Intel ,
Inter Partes Review (IPR) Proceeding ,
Moderna Inc. ,
Mylan Pharmaceuticals ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Prior Art ,
Qualcomm
It’s No Secret That a Related Company’s Physical Presence in a Jurisdiction May Not Be Enough For Proper Venue -
In Andra Group, LP v. Victoria’s Secret Stores, LLC, Appeal No. 20-2009, The Federal Circuit held that an...more
9/20/2021
/ Abstract Ideas ,
Eli Lilly ,
Improper Venue ,
Inter Partes Review (IPR) Proceeding ,
Jurisdiction ,
Nexus ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Physical Presence Test ,
Preamble ,
Principal Place of Business ,
Retailers ,
Teva Pharmaceuticals ,
Victoria Secret
Copying From a Copyrighted Computer Program May Be Fair Use to the Extent Needed to Promote Adoption of the Use of Accrued Talents in Creating a New Software Platform -
In Google LLC v. Oracle America, Inc., Appeal No....more
5/28/2021
/ Admissible Evidence ,
Copyright ,
Copyright Infringement ,
Fair Use ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Oracle v Google ,
Patent Royalties ,
Prior Art ,
SCOTUS ,
Software Developers ,
Source Code ,
Transformative Use
Evidence Supports Prior Art’s Public Accessibility but Not the Board’s Adoption of an Unpresented Theory of Anticipation -
In M & K Holdings, Inc. v. Samsung Electronics Co.,Ltd., Appeal No. 20-1160, the Federal Circuit...more
3/26/2021
/ Abstract Ideas ,
Anticipation ,
Article III ,
Covered Business Method Proceedings ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Printed Publications ,
Prior Art ,
Section 102
No Shortcuts to the “Reasonable Pertinence” Analysis in the Analogous Art Inquiry -
In Donner Technology, LLC v. Pro Stage Gear, LLC, Appeal No. 20-1104, the Federal Circuit determination as to whether a reference is...more
12/23/2020
/ Analogous Art ,
Claim Construction ,
Covered Business Method Patents ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
POSITA ,
Prior Art ,
Thryv Inc v Click-To-Call Technologies LP
Unconstitutionally Appointed Judges Cannot Decide Ex Parte Appeals -
In In Re Boloro Global Limited, Appeal No. 19-2349, When administrative patent judges are unconstitutionally appointed, their decisions in ex...more
9/1/2020
/ Administrative Patent Judges ,
Claim Construction ,
Constitutional Challenges ,
Eleventh Amendment ,
Ex Parte ,
Final Written Decisions ,
Inter Partes Reexamination ,
Obviousness ,
Patent Applications ,
Patent Prosecution History ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Remand ,
SAS Institute Inc. v Iancu ,
Sovereign Immunity ,
Vacated
Non-Infringement Need Not Be “Actually Litigated” To Shield Accused Products From Infringement Liability In Subsequent Actions -
In In Re Personal Web Technologies LLC, Appeal No. 19-1918, the Federal Circuit ruled that the...more
8/4/2020
/ Appeals ,
Claim Limitations ,
Claim Preclusion ,
Declaratory Judgments ,
Dismissal With Prejudice ,
Inter Partes Review (IPR) Proceeding ,
Issue Preclusion ,
Kessler Doctrine ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Popular ,
Preamble ,
Prior Art
PTAB May Not Cancel Claims on the Grounds of Indefiniteness in an IPR Proceeding -
In Samsung Electronics America v. Prisua Engineering Corp., Appeal No. 19-1169, the Federal Circuit held that the Patent Trial and Appeal...more
3/9/2020
/ Claim Construction ,
Indefiniteness ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Principal Place of Business ,
Prior Art ,
Section 112 ,
Venue ,
Writ of Mandamus
Specification’s Narrow Description of the Invention Results in Disavowal of Claim Scope -
In Techtronic Industries Co. Ltd. v. ITC., Appeal No. 18-2191, the consistent description in the specification of a particular...more
1/27/2020
/ Administrative Law Judge (ALJ) ,
Exceptional Case ,
Food and Drug Administration (FDA) ,
Intellectual Property Protection ,
International Trade Commission (ITC) ,
New Evidence ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Prior Art
The Appointments Clause: Ensuring That PTAB Decisions Are Subject to Constitutional Checks and Balances
In Arthrex, Inc. v. Smith & Nephew, Inc., Appeal No. 18-2251, the Federal Circuit ruled that, under the then-existing...more
12/30/2019
/ Abstract Ideas ,
Administrative Appeals ,
Administrative Patent Judges ,
Anticipatory Reference ,
Appeals ,
Appointments Clause ,
Claim Limitations ,
Constitutional Challenges ,
Declaration ,
Final Written Decisions ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Applications ,
Patent Examinations ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Preamble ,
Presidential Appointments ,
Prior Art ,
Process Improvement ,
Publicly Accessible Data ,
Reaffirmation ,
Reversal ,
Severability Doctrine ,
Supplemental Evidence ,
Written Notice
One-year Clock for Filing IPR Petition Applies to Litigants and Parties that Become Privies of the Litigant Prior to Institution.
In Power Integrations, Inc v. Semiconductor Components, Appeal No. 2018-1607, the Federal...more
7/16/2019
/ § 315(b) ,
Appeals ,
Claim Construction ,
Doctrine of Equivalents ,
First Amendment ,
Iancu v. Brunetti ,
In Rem Jurisdiction ,
Inter Partes Review (IPR) Proceeding ,
Mergers ,
Motion to Dismiss ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent Validity ,
Patents ,
Prior Art ,
Privity of Contract ,
Prosecution History Estoppel ,
Reaffirmation ,
Reversal ,
Samsung ,
Sovereign Immunity ,
State Universities ,
Time-Barred Claims ,
Tribal Governments ,
USPTO ,
Viewpoint Discrimination
Reasonably Continuous Diligence Is Not Negated If an Inventor Works On Improvements or Evaluates Alternatives to the Claimed Invention -
In ATI Technologies ULC v. IANCU, Appeal Nos. 2016-2222, -2406, -2608, the Federal...more
6/19/2019
/ Abstract Ideas ,
Appeals ,
Clinical Trials ,
CLS Bank v Alice Corp ,
Covered Business Method Proceedings ,
Eli Lilly ,
Graphical User Interface ,
Inter Partes Review (IPR) Proceeding ,
Nonobvious ,
Obviousness ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent Validity ,
Patent-Eligible Subject Matter ,
Patents ,
Prior Art ,
Reaffirmation ,
Reasonably Continuous Exercise of Diligence Standard ,
Reversal ,
Seventh Amendment ,
Trading Platforms
Just Because Something May Result From a Prior Art Teaching Does Not Make it Inherent in that Teaching -
In Personal Web Technologies, LLC v. Apple, Inc., Appeal No. 2018-1599, the Federal Circuit clarified that the mere...more
5/10/2019
/ Abstract Ideas ,
Appeals ,
Apple ,
Claim Construction ,
CLS Bank v Alice Corp ,
Diagnostic Method ,
Dismissal With Prejudice ,
Inherency ,
Inter Partes Review (IPR) Proceeding ,
Jury Trial ,
Mayo v. Prometheus ,
Motion for JMOL ,
Motion for Summary Judgment ,
Motion to Dismiss ,
Obviousness ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Preamble ,
Prior Art ,
Product of Nature Doctrine ,
Reaffirmation ,
Remand ,
Reversal ,
Section 101 ,
Substantial Evidence Standard ,
Summary Judgment ,
Treatment Method Patents ,
Willful Infringement
PTAB May Invalidate Claims on Reconsideration Based on Grounds Raised in the Institution Decision that Were Not Originally Instituted -
In AC Technologies S.A., V. Amazon.Com, Inc., Blizzard Entertainment, Inc., Appeal No....more
3/14/2019
/ Abbreviated New Drug Application (ANDA) ,
Amazon ,
Anticipation ,
Appeals ,
Article III ,
Due Process ,
Final Written Decisions ,
Generic Drugs ,
Hatch-Waxman ,
Hewlett-Packard ,
Inter Partes Review (IPR) Proceeding ,
Motivation to Combine ,
Mylan Pharmaceuticals ,
Obviousness ,
Orange Book ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Petition For Rehearing ,
Pharmaceutical Patents ,
Reaffirmation ,
Right To Appeal ,
Section 103 ,
Standing
IPR Petitioner’s Initial Identification of the Real Parties in Interest Is to Be Accepted Unless and Until Disputed by a Patent Owner -
In Worlds Inc. v. Bungie, Inc., Appeal Nos. 2017-1481, -1546, -1583, the Federal...more
11/14/2018
/ § 315(b) ,
Appeals ,
Burden of Persuasion ,
Burden of Proof ,
Burden-Shifting ,
Dismissals ,
Evidence ,
Inter Partes Review (IPR) Proceeding ,
Lack of Authority ,
Method Claims ,
Motivation to Combine ,
Obviousness ,
Patent Infringement ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Reaffirmation ,
Real Party in Interest ,
Rebuttable Presumptions ,
Remand ,
Reversal ,
Sanctions ,
Time-Barred Claims ,
Vacated
The Board’s Final Written Decision Must Address All Grounds for Unpatentability Raised in a Petition for Inter Partes Review -
In Adidas AG v. Nike, Inc., Appeal Nos. 2018-1180, 2018-1181, the Federal Circuit held that...more
8/30/2018
/ Adidas ,
Anticipation ,
Appeals ,
Broadest Reasonable Interpretation Standard ,
Calculation of Damages ,
Claim Construction ,
Combined References ,
Enhanced Damages ,
Fair Market Value ,
Final Written Decisions ,
Genuine Issue of Material Fact ,
Inter Partes Review (IPR) Proceeding ,
Jury Trial ,
Motivation to Combine ,
Nike ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent Validity ,
Patents ,
Prior Art ,
Public Use ,
Reaffirmation ,
Rebuttable Presumptions ,
Remand ,
SAS Institute Inc. v Iancu ,
Substantial Evidence Standard ,
Vacated ,
Willful Infringement